TABLE 3.
Clinical Outcomes by Study Group a
| Outcome | CBD (n = 42) | Control (n = 40) | P |
|---|---|---|---|
| VAS pain | 0.8 ± 1.6 | 1.2 ± 1.8 | .38 |
| ASES | 93.0 ± 13.9 | 91.1 ± 15.0 | .71 |
| Activities of daily living | 45.7 ± 7.4 | 46.2 ± 5.7 | .76 |
| Achieved PASS | 34 (81.0) | 31 (77.5) | .79 |
| SANE | 87.6 ± 12.2 | 90.1 ± 13.1 | .24 |
| VAS satisfaction | 97.4 ± 5.2 | 95.4 ± 9.9 | .41 |
| Surgery met expectations | 42 (100) | 39 (97.5) | .49 |
| Willing to repeat | 40 (95.2) | 39 (97.5) | .62 |
a
Data reported as mean ± SD or n (%). ASES, American Shoulder and Elbow Surgeons Shoulder Score; CBD, cannabidiol; PASS, Patient Acceptable Symptom State; SANE, single assessment numeric evaluation; VAS, visual analogue scale.